{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:03:51Z","timestamp":1769508231553,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Children\u2019s Glaucoma Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-92273-5","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T17:27:37Z","timestamp":1741368457000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["AAV-IKV mediated expression of decorin inhibits EMT and fibrosis in a murine model of Glaucoma and AAV-IKV transduction in Non-Human Primates"],"prefix":"10.1038","volume":"15","author":[{"given":"Pushpa","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siobhan M.","family":"Cashman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Walton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra","family":"Kumar-Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"92273_CR1","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham, Y. C. et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology121, 2081\u20132090. https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.013 (2014).","journal-title":"Ophthalmology"},{"key":"92273_CR2","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1080\/08035250310007556","volume":"92","author":"A Foster","year":"2003","unstructured":"Foster, A. & Gilbert, C. Cataract in children. Acta Paediatr.92, 1376\u20131378. https:\/\/doi.org\/10.1080\/08035250310007556 (2003).","journal-title":"Acta Paediatr."},{"key":"92273_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jaapos.2008.10.020","volume":"13","author":"AO Khan","year":"2009","unstructured":"Khan, A. O. & Al-Dahmash, S. Age at the time of cataract surgery and relative risk for Aphakic glaucoma in nontraumatic infantile cataract. J. AAPOS. 13, 166\u2013169. https:\/\/doi.org\/10.1016\/j.jaapos.2008.10.020 (2009).","journal-title":"J. AAPOS"},{"key":"92273_CR4","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1056\/NEJMc090757","volume":"360","author":"J Kountouras","year":"2009","unstructured":"Kountouras, J., Zavos, C. & Deretzi, G. Primary open-angle glaucoma. N Engl. J. Med.360, 2679 (2009). author reply 2679\u20132680.","journal-title":"N Engl. J. Med."},{"key":"92273_CR5","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb, R. N., Aung, T. & Medeiros, F. A. The pathophysiology and treatment of glaucoma: a review. JAMA311, 1901\u20131911. https:\/\/doi.org\/10.1001\/jama.2014.3192 (2014).","journal-title":"JAMA"},{"key":"92273_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.22608\/APO.2018298","volume":"7","author":"PL Kaufman","year":"2018","unstructured":"Kaufman, P. L., Mohr, M. E., Riccomini, S. P. & Rasmussen, C. A. Glaucoma drugs in the pipeline. Asia Pac. J. Ophthalmol. (Phila). 7, 345\u2013351. https:\/\/doi.org\/10.22608\/APO.2018298 (2018).","journal-title":"Asia Pac. J. Ophthalmol. (Phila)"},{"key":"92273_CR7","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1080\/13543784.2016.1223042","volume":"25","author":"JA Lusthaus","year":"2016","unstructured":"Lusthaus, J. A. & Goldberg, I. Investigational and experimental drugs for intraocular pressure reduction in ocular hypertension and glaucoma. Expert Opin. Investig. Drugs. 25, 1201\u20131208. https:\/\/doi.org\/10.1080\/13543784.2016.1223042 (2016).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"92273_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/eye.2011.309","volume":"26","author":"M Gemenetzi","year":"2012","unstructured":"Gemenetzi, M., Yang, Y. & Lotery, A. J. Current concepts on primary open-angle glaucoma genetics: a contribution to disease pathophysiology and future treatment. Eye (Lond). 26, 355\u2013369. https:\/\/doi.org\/10.1038\/eye.2011.309 (2012).","journal-title":"Eye (Lond)"},{"key":"92273_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1006\/exer.1994.1158","volume":"59","author":"RC Tripathi","year":"1994","unstructured":"Tripathi, R. C., Li, J., Chan, W. F. & Tripathi, B. J. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp. Eye Res.59, 723\u2013727. https:\/\/doi.org\/10.1006\/exer.1994.1158 (1994).","journal-title":"Exp. Eye Res."},{"key":"92273_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s004170000241","volume":"239","author":"M Inatani","year":"2001","unstructured":"Inatani, M. et al. Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefes Arch. Clin. Exp. Ophthalmol.239, 109\u2013113. https:\/\/doi.org\/10.1007\/s004170000241 (2001).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"92273_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s004170000252","volume":"239","author":"G Picht","year":"2001","unstructured":"Picht, G., Welge-Luessen, U., Grehn, F. & Lutjen-Drecoll, E. Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch. Clin. Exp. Ophthalmol.239, 199\u2013207. https:\/\/doi.org\/10.1007\/s004170000252 (2001).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"92273_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/s0021-5155(01)00523-8","volume":"46","author":"Y Ochiai","year":"2002","unstructured":"Ochiai, Y. & Ochiai, H. Higher concentration of transforming growth factor-beta in aqueous humor of glaucomatous eyes and diabetic eyes. Jpn J. Ophthalmol.46, 249\u2013253. https:\/\/doi.org\/10.1016\/s0021-5155(01)00523-8 (2002).","journal-title":"Jpn J. Ophthalmol."},{"key":"92273_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1023\/b:inte.0000018524.48581.79","volume":"25","author":"AA Ozcan","year":"2004","unstructured":"Ozcan, A. A., Ozdemir, N. & Canataroglu, A. The aqueous levels of TGF-beta2 in patients with glaucoma. Int. Ophthalmol.25, 19\u201322. https:\/\/doi.org\/10.1023\/b:inte.0000018524.48581.79 (2004).","journal-title":"Int. Ophthalmol."},{"key":"92273_CR14","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.1167\/iovs.19-27091","volume":"60","author":"S NikhalaShree","year":"2019","unstructured":"NikhalaShree, S. et al. Lowered decorin with aberrant extracellular matrix remodeling in aqueous humor and Tenon\u2019s tissue from primary Glaucoma patients. Invest. Ophthalmol. Vis. Sci.60, 4661\u20134669. https:\/\/doi.org\/10.1167\/iovs.19-27091 (2019).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"92273_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3341\/kjo.2006.20.3.162","volume":"20","author":"SH Min","year":"2006","unstructured":"Min, S. H., Lee, T. I., Chung, Y. S. & Kim, H. K. Transforming growth factor-beta levels in human aqueous humor of glaucomatous, diabetic and uveitic eyes. Korean J. Ophthalmol.20, 162\u2013165. https:\/\/doi.org\/10.3341\/kjo.2006.20.3.162 (2006).","journal-title":"Korean J. Ophthalmol."},{"key":"92273_CR16","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3109\/02713689009069932","volume":"9","author":"HD Jampel","year":"1990","unstructured":"Jampel, H. D., Roche, N., Stark, W. J. & Roberts, A. B. Transforming growth factor-beta in human aqueous humor. Curr. Eye Res.9, 963\u2013969. https:\/\/doi.org\/10.3109\/02713689009069932 (1990).","journal-title":"Curr. Eye Res."},{"key":"92273_CR17","first-page":"612","volume":"21","author":"P Agarwal","year":"2015","unstructured":"Agarwal, P., Daher, A. M. & Agarwal, R. Aqueous humor TGF-beta2 levels in patients with open-angle glaucoma: A meta-analysis. Mol. Vis.21, 612\u2013620 (2015).","journal-title":"Mol. Vis."},{"key":"92273_CR18","doi-asserted-by":"publisher","unstructured":"Sisto, M., Ribatti, D. & Lisi, S. Organ Fibrosis and Autoimmunity: The Role of Inflammation in TGFbeta-Dependent EMT. Biomolecules 11, (2021). https:\/\/doi.org\/10.3390\/biom11020310","DOI":"10.3390\/biom11020310"},{"key":"92273_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28160","author":"V Das","year":"2019","unstructured":"Das, V., Bhattacharya, S., Chikkaputtaiah, C., Hazra, S. & Pal, M. The basics of epithelial-mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective. J. Cell. Physiol.https:\/\/doi.org\/10.1002\/jcp.28160 (2019).","journal-title":"J. Cell. Physiol."},{"key":"92273_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3928\/01913913-20100518-04","volume":"48","author":"I Michael","year":"2011","unstructured":"Michael, I., Walton, D. S. & Levenberg, S. Infantile Aphakic glaucoma: a proposed etiologic role of IL-4 and VEGF. J. Pediatr. Ophthalmol. Strabismus. 48, 98\u2013107. https:\/\/doi.org\/10.3928\/01913913-20100518-04 (2011).","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"92273_CR21","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3928\/01913913-20210929-02","volume":"59","author":"HH Yeung","year":"2022","unstructured":"Yeung, H. H., Kumar-Singh, R. & Walton, D. S. Infantile Aphakic glaucoma: A proposed mechanism. J. Pediatr. Ophthalmol. Strabismus. 59, 236\u2013242. https:\/\/doi.org\/10.3928\/01913913-20210929-02 (2022).","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"92273_CR22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ajpath.2012.04.029","volume":"181","author":"T Neill","year":"2012","unstructured":"Neill, T., Schaefer, L. & Iozzo, R. V. Decorin: a guardian from the matrix. Am. J. Pathol.181, 380\u2013387. https:\/\/doi.org\/10.1016\/j.ajpath.2012.04.029 (2012).","journal-title":"Am. J. Pathol."},{"key":"92273_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2021.02.002","author":"M Schneider","year":"2021","unstructured":"Schneider, M. et al. A novel ocular function for decorin in the aqueous humor outflow. Matrix Biol.https:\/\/doi.org\/10.1016\/j.matbio.2021.02.002 (2021).","journal-title":"Matrix Biol."},{"key":"92273_CR24","doi-asserted-by":"publisher","first-page":"109199","DOI":"10.1016\/j.exer.2022.109199","volume":"224","author":"S Nikhalashree","year":"2022","unstructured":"Nikhalashree, S. et al. Anti-glaucoma medications Lowered decorin and altered profibrotic proteins in human Tenon\u2019s fibroblasts. Exp. Eye Res.224, 109199. https:\/\/doi.org\/10.1016\/j.exer.2022.109199 (2022).","journal-title":"Exp. Eye Res."},{"key":"92273_CR25","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1167\/iovs.14-15622","volume":"56","author":"LJ Hill","year":"2015","unstructured":"Hill, L. J. et al. Decorin reduces intraocular pressure and retinal ganglion cell loss in rodents through fibrolysis of the scarred trabecular meshwork. Invest. Ophthalmol. Vis. Sci.56, 3743\u20133757. https:\/\/doi.org\/10.1167\/iovs.14-15622 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"92273_CR26","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1167\/iovs.09-4567","volume":"51","author":"AR Shepard","year":"2010","unstructured":"Shepard, A. R. et al. Adenoviral gene transfer of active human transforming growth factor-{beta}2 elevates intraocular pressure and reduces outflow facility in rodent eyes. Invest. Ophthalmol. Vis. Sci.51, 2067\u20132076. https:\/\/doi.org\/10.1167\/iovs.09-4567 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"92273_CR27","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","volume":"6","author":"V Agrahari","year":"2016","unstructured":"Agrahari, V. et al. A comprehensive insight on ocular pharmacokinetics. Drug Deliv Transl Res.6, 735\u2013754. https:\/\/doi.org\/10.1007\/s13346-016-0339-2 (2016).","journal-title":"Drug Deliv Transl Res."},{"key":"92273_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2174\/1874364101711010305","volume":"11","author":"A Vaajanen","year":"2017","unstructured":"Vaajanen, A. & Vapaatalo, H. A single drop in the Eye - Effects on the whole body?? Open. Ophthalmol. J.11, 305\u2013314. https:\/\/doi.org\/10.2174\/1874364101711010305 (2017).","journal-title":"Open. Ophthalmol. J."},{"key":"92273_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1146\/annurev-vision-102016-061422","volume":"3","author":"M Almasieh","year":"2017","unstructured":"Almasieh, M. & Levin, L. A. Neuroprotection in glaucoma: animal models and clinical trials. Annu. Rev. Vis. Sci.3, 91\u2013120. https:\/\/doi.org\/10.1146\/annurev-vision-102016-061422 (2017).","journal-title":"Annu. Rev. Vis. Sci."},{"key":"92273_CR30","doi-asserted-by":"publisher","unstructured":"Kumar, B., Mishra, M., Cashman, S. & Kumar-Singh, R. Retinal Penetrating Adeno-Associated Virus. Invest Ophthalmol Vis Sci In press, (2024). https:\/\/doi.org\/10.1167\/iovs.65.8.31","DOI":"10.1167\/iovs.65.8.31"},{"key":"92273_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1167\/iovs.65.8.31","volume":"65","author":"B Kumar","year":"2024","unstructured":"Kumar, B., Mishra, M., Talreja, D., Cashman, S. & Kumar-Singh, R. Cell-Penetrating chaperone Nuc1 for Small- and Large-Molecule delivery into retinal cells and tissues. Invest. Ophthalmol. Vis. Sci.65, 31. https:\/\/doi.org\/10.1167\/iovs.65.8.31 (2024).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"92273_CR32","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1167\/iovs.06-0183","volume":"47","author":"A Maeda","year":"2006","unstructured":"Maeda, A. et al. Circadian intraocular pressure rhythm is generated by clock genes. Invest. Ophthalmol. Vis. Sci.47, 4050\u20134052. https:\/\/doi.org\/10.1167\/iovs.06-0183 (2006).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"92273_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41434-019-0105-4","volume":"27","author":"L Rodriguez-Estevez","year":"2020","unstructured":"Rodriguez-Estevez, L., Asokan, P. & Borras, T. Transduction optimization of AAV vectors for human gene therapy of glaucoma and their reversed cell entry characteristics. Gene Ther.27, 127\u2013142. https:\/\/doi.org\/10.1038\/s41434-019-0105-4 (2020).","journal-title":"Gene Ther."},{"key":"92273_CR34","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1089\/hum.2020.070","volume":"31","author":"A Frederick","year":"2020","unstructured":"Frederick, A. et al. Engineered capsids for efficient gene delivery to the retina and cornea. Hum. Gene Ther.31, 756\u2013774. https:\/\/doi.org\/10.1089\/hum.2020.070 (2020).","journal-title":"Hum. Gene Ther."},{"key":"92273_CR35","doi-asserted-by":"publisher","first-page":"e0182473","DOI":"10.1371\/journal.pone.0182473","volume":"12","author":"L Wang","year":"2017","unstructured":"Wang, L., Xiao, R., Andres-Mateos, E. & Vandenberghe, L. H. Single stranded adeno-associated virus achieves efficient gene transfer to anterior segment in the mouse eye. PLoS One. 12, e0182473. https:\/\/doi.org\/10.1371\/journal.pone.0182473 (2017).","journal-title":"PLoS One"},{"key":"92273_CR36","doi-asserted-by":"publisher","first-page":"e0128759","DOI":"10.1371\/journal.pone.0128759","volume":"10","author":"B Bogner","year":"2015","unstructured":"Bogner, B. et al. Capsid mutated Adeno-Associated virus delivered to the anterior chamber results in efficient transduction of trabecular meshwork in mouse and rat. PLoS One. 10, e0128759. https:\/\/doi.org\/10.1371\/journal.pone.0128759 (2015).","journal-title":"PLoS One"},{"key":"92273_CR37","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.exer.2010.01.011","volume":"90","author":"F Kong","year":"2010","unstructured":"Kong, F. et al. Self-complementary AAV5 vector facilitates quicker transgene expression in photoreceptor and retinal pigment epithelial cells of normal mouse. Exp. Eye Res.90, 546\u2013554. https:\/\/doi.org\/10.1016\/j.exer.2010.01.011 (2010).","journal-title":"Exp. Eye Res."},{"key":"92273_CR38","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1167\/iovs.09-3847","volume":"51","author":"LK Buie","year":"2010","unstructured":"Buie, L. K. et al. Self-complementary AAV virus (scAAV) safe and long-term gene transfer in the trabecular meshwork of living rats and monkeys. Invest. Ophthalmol. Vis. Sci.51, 236\u2013248. https:\/\/doi.org\/10.1167\/iovs.09-3847 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"92273_CR39","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/mt.2008.171","volume":"16","author":"DM McCarty","year":"2008","unstructured":"McCarty, D. M. Self-complementary AAV vectors; advances and applications. Mol. Ther.16, 1648\u20131656. https:\/\/doi.org\/10.1038\/mt.2008.171 (2008).","journal-title":"Mol. Ther."},{"key":"92273_CR40","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","volume":"8","author":"DM McCarty","year":"2001","unstructured":"McCarty, D. M., Monahan, P. E. & Samulski, R. J. Self-complementary Recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther.8, 1248\u20131254. https:\/\/doi.org\/10.1038\/sj.gt.3301514 (2001).","journal-title":"Gene Ther."},{"key":"92273_CR41","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/cne.903360405","volume":"336","author":"CF Marfurt","year":"1993","unstructured":"Marfurt, C. F. & Ellis, L. C. Immunohistochemical localization of tyrosine hydroxylase in corneal nerves. J. Comp. Neurol.336, 517\u2013531. https:\/\/doi.org\/10.1002\/cne.903360405 (1993).","journal-title":"J. Comp. Neurol."},{"key":"92273_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/s0301-0082(01)00021-1","volume":"66","author":"NE Lazarov","year":"2002","unstructured":"Lazarov, N. E. Comparative analysis of the chemical neuroanatomy of the mammalian trigeminal ganglion and mesencephalic trigeminal nucleus. Prog Neurobiol.66, 19\u201359. https:\/\/doi.org\/10.1016\/s0301-0082(01)00021-1 (2002).","journal-title":"Prog Neurobiol."},{"key":"92273_CR43","first-page":"2252","volume":"42","author":"CJ Murphy","year":"2001","unstructured":"Murphy, C. J. et al. Spontaneous chronic corneal epithelial defects (SCCED) in dogs: clinical features, innervation, and effect of topical SP, with or without IGF-1. Invest. Ophthalmol. Vis. Sci.42, 2252\u20132261 (2001).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"92273_CR44","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/s0002-9394(01)00995-3","volume":"132","author":"SE Wilson","year":"2001","unstructured":"Wilson, S. E. & Ambrosio, R. Laser in situ keratomileusis-induced neurotrophic epitheliopathy. Am. J. Ophthalmol.132, 405\u2013406. https:\/\/doi.org\/10.1016\/s0002-9394(01)00995-3 (2001).","journal-title":"Am. J. Ophthalmol."},{"key":"92273_CR45","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1007\/s00417-018-4105-7","volume":"256","author":"AM Abdullatif","year":"2018","unstructured":"Abdullatif, A. M. et al. Intravitreal decorin preventing proliferative vitreoretinopathy in perforating injuries: a pilot study. Graefes Arch. Clin. Exp. Ophthalmol.256, 2473\u20132481. https:\/\/doi.org\/10.1007\/s00417-018-4105-7 (2018).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92273-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92273-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92273-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T17:27:44Z","timestamp":1741368464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92273-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92273"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92273-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8051"}}